Advisor Group, Inc. - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 72 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 248.60 and the average weighting 1.0%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$20,000
+566.7%
906
+353.0%
0.00%
Q3 2019$3,0000.0%2000.0%0.00%
Q2 2019$3,0000.0%2000.0%0.00%
Q1 2019$3,000
+50.0%
2000.0%0.00%
Q4 2018$2,000
-33.3%
2000.0%0.00%
Q3 2018$3,000
+50.0%
2000.0%0.00%
Q2 2018$2,000
-60.0%
200
-60.0%
0.00%
Q1 2018$5,0000.0%5000.0%0.00%
Q4 2017$5,0005000.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 4,080,237$103,638,00010.86%
Aquilo Capital Management, LLC 1,454,686$36,949,0007.45%
RTW INVESTMENTS, LP 7,152,918$181,684,0005.11%
EcoR1 Capital, LLC 2,721,993$69,139,0005.11%
BRIDGER MANAGEMENT, LLC 1,473,568$37,429,0003.47%
DAFNA Capital Management LLC 454,236$11,538,0003.33%
Parkman Healthcare Partners LLC 300,805$7,640,0002.15%
ACUTA CAPITAL PARTNERS, LLC 170,000$4,318,0001.25%
Integral Health Asset Management, LLC 110,000$2,794,0000.84%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,013,087$25,732,0000.63%
View complete list of DICERNA PHARMACEUTICALS INC shareholders